A private equity firm founded in the USA invests in companies with high growth potential. The firm also considers in-licensing of technologies and strategic acquisitions. For equity investments, the firm prefers that companies are located in the Eastern US and Midwest, but for acquisitions and in-licensing, the firm will consider companies located around the globe. The firm also has an early-stage focused fund through which the firm makes angel investments into high potential, early-stage companies. With this fund, the firm typically invests up to $250K in preferred equity.
The firm primarily focuses on the following sectors: Diagnostics (including digital), Pharma Services/Outsourcing, Digital Health, and Medical Devices. The firm has a strong preference for companies working with platform technologies. For equity investments, the firm looks for companies that have reached commercialization. With regards to their early-stage fund, the firm primarily seeks companies in healthcare services and SaaS outsourcing businesses.
The firm is looking for experienced management teams with domain expertise and leadership skills that are capable of taking the company to the next value inflection point or additional capital raise. The firm is interested in company that are profitable or near breakeven and have demonstrated substantial opportunity for growth.
If you are interested in more information about this investor and other investors tracked by LSN, please emailĀ mandates@lifesciencenation.com.
Artificial intelligence (AI) and sensor technology used in implantable and wearable devices and managed care solutions use smart, natural language-based agents to help clinicians and patients with chronic disease management. Rick co-founded Thermalin, which is developing the StampPump ā a postage-stamp-sized, wearable, intelligent glucose management system for people with T1 and T2 diabetes. As a connected sensor platform, StampPump will deliver continuous metabolic telemetry that, with the assistance of machine learning algorithms, will enable physicians to better coach diabetes patients and fine-tune their glucose control algorithms. Rick raised the funding, built the scientific and business teams, and drives the companyās strategy. Rick received a JD-MBA from Harvard Business and Law Schools in 1984, then worked for Bell Laboratories and an AI startup before joining McKinsey & Company. He subsequently became a serial entrepreneur who has previously launched and financed multiple life science organizations.
Paul Pyzowski is the founder and CEO of Altimate Health. Altimate is leading the development of precision psychiatry, applying data science to identify and guide treatment for patients with psychiatric and other behavioral health disorders. Paul has a diverse entrepreneurial and executive background that includes Parkinsonās disease therapeutics, therapies for pediatric epilepsy, rapid DNA sequencing, clinical laboratories for addiction medicine, and computational physics. BSEE from Carnegie-Mellon, MBA from the Institute for Management Development in Switzerland.
Shah was most recently Global Director of Marketing for the Informatics Software business within Thermo Fisher Scientific, a $20 Billion company whose mission is to enable their customers to make the world healthier, cleaner and safer. During his career, Shah has held executive level positions at a number of high-tech companies such as Lotus Development, Micrografx and Inso Corporation. Shah is an experienced Marketing Executive with a demonstrated history of working in the research industry. Skilled in Product Management, Advertising, Enterprise Software, Sales, Entrepreneurship, and Customer Relationship Management (CRM). Strong marketing professional with an MBA focused in Business Administration from MIT Sloan School.
Karolina is currently the CEO of Nutrimedy, a digital health solution focused on transforming clinical nutrition care in oncology, heart failure, kidney disease, and inflammatory bowel disease. As a registered and licensed clinical dietitian, Karolina incorporates her multi-dimensional background in healthcare to uncover innovative solutions aimed at addressing cost drivers and improving health outcomes. Over the past 15 years, her career evolved from the emergency services field to digital startups and workplace wellness. From small local employers to Fortune 500 companies, Karolina has led and designed data-driven, award-winning programs that improve employee wellbeing and help curtail future healthcare spend. Karolina received her BS in Nutrition and Food Science from Montclair State University, completed her post-baccalaureate dietetic residency at Rutgers University, and completed her Master in Healthcare Leadership at Brown University.
Next Phase Newsletter 